Accès ouvert
2022
article
OpenAlex
P. Abratenko, R. An, J. Anthony, L. Arellano et autres
Obtaining a high-quality interaction model with associated uncertainties is essential for neutrino experiments studying oscillations, nuclear scattering processes, or both. As a primary input to the MicroBooNE experiment's next generation of neutrino cross section measurements and its flagship investigation of the MiniBooNE …
us, gb, il, ch, es
(code pays fourni par la source)
Accès ouvert
2021
preprint
OpenAlex
P. Abratenko, R. An, J. Anthony, L. Arellano et autres
This article presents a measurement of $\nu_e$ interactions without pions in the final state using the MicroBooNE experiment and an investigation into the excess of low-energy electromagnetic events observed by the MiniBooNE collaboration. The measurement is performed in exclusive channels with (1$e$N$p$0$\pi$) …
Accès ouvert
2021
preprint
OpenAlex
MicroBooNE collaboration, P. Abratenko, R. An, J. Anthony et autres
This article presents a measurement of $ν_e$ interactions without pions in the final state using the MicroBooNE experiment and an investigation into the excess of low-energy electromagnetic events observed by the MiniBooNE collaboration. The measurement is performed in exclusive channels with (1$e$N$p$0$π$) …
Accès ouvert
2021
preprint
OpenAlex
MicroBooNE collaboration, P. Abratenko, R. An, J. Anthony et autres
We present a measurement of electron neutrino interactions from the Fermilab Booster Neutrino Beam using the MicroBooNE liquid argon time projection chamber to address the nature of the excess of low energy interactions observed by the MiniBooNE collaboration. Three independent electron neutrino …
Accès ouvert
2015
article
OpenAlex
Enchi Liu, Mark E. Schmidt, Richard Margolin, Reisa A. Sperling et autres
OBJECTIVE: To evaluate the effects of bapineuzumab on brain β-amyloid (Aβ) burden using (11)C-Pittsburgh compound B ((11)C-PiB)-PET. METHODS: Two phase 3 clinical trials, 1 each in apolipoprotein APOE ε4 carriers and noncarriers, were conducted in patients with mild to moderate Alzheimer disease …
be, gb, us
(code pays fourni par la source)